ziprasidone monohydrate
SpainDrugs containing this active substance
-
It is used in adults for the treatment of schizophrenia and in adults, children, and adolescents aged 10 to 17 to treat manic symptoms in bipolar disorder.
Form: capsules, hard
Active substance Dosage ziprasidone monohydrate 22,63 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to treat schizophrenia in adults and to treat manic symptoms in bipolar disorder in adults, children, and adolescents aged between 10 and 17 years.
Form: capsules, hard
Active substance Dosage ziprasidone monohydrate 45.274 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to treat schizophrenia in adults and to treat manic symptoms in bipolar disorder in adults, as well as in children and adolescents aged 10 to 17 years.
Form: capsules, hard
Active substance Dosage ziprasidone monohydrate 67,9 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to treat schizophrenia in adults and to treat manic symptoms in bipolar disorder in adults, children, and adolescents between 10 and 17 years of age.
Form: capsules, hard
Active substance Dosage ziprasidone monohydrate 90.559 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to treat schizophrenia in adults and manic or mixed episodes of bipolar disorder in adults and in children and adolescents aged 10 to 17 years.
Form: capsules, hard
Active substance Dosage ziprasidone monohydrate 21,77 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat schizophrenia in adults and manic or mixed episodes of bipolar disorder in adults and in children and adolescents aged 10 to 17 years.
Form: capsules, hard
Active substance Dosage ziprasidone monohydrate 43,54 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat schizophrenia in adults and manic or mixed episodes of bipolar disorder in adults and in children and adolescents aged 10 to 17 years.
Form: capsules, hard
Active substance Dosage ziprasidone monohydrate 65,31 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat schizophrenia in adults and manic or mixed episodes of bipolar disorder in adults and in children and adolescents aged 10 to 17 years.
Form: capsules, hard
Active substance Dosage ziprasidone monohydrate 87,08 mg Manufacturer: Sandoz Farmaceutica S.A.